|国家科技期刊平台
首页|期刊导航|临床与病理杂志|HMGB1在浸润性喉鳞状细胞癌发生和发展中的作用及临床意义

HMGB1在浸润性喉鳞状细胞癌发生和发展中的作用及临床意义OA

Clinical significance and role of HMGB1 in the occurrence and development of invasive laryngeal squamous cell carcinoma

中文摘要英文摘要

目的:浸润性喉鳞状细胞癌(invasive laryngeal squamous cell carcinoma,I-LSCC)早期诊断、早期干预治疗是降低其发病率和病死率的关键.本研究旨在探讨高迁移率族蛋白B1(high mobility group box-1,HMGB1)在I-LSCC发生和发展中的作用及临床意义.方法:收集2009年11月至2011年6月北京同仁医院病理科的石蜡包埋标本281例,包括I-LSCC 123例、喉黏膜异型增生(laryngeal precursor lesions,LPLs)103例(其中低级别异型增生31例、高级别异型增生49例、原位癌23例)及声带息肉(vocal polyp,VP)55例.应用免疫组织化学染色检测标本中HMGB1及Ki-67的表达,其中HMGB1阳性强度和阳性率得分相加总分为0~7(0~4分为低表达,5~7分为高表达);Ki-67阳性率≥50%为高表达,<50%为低表达.结果:HMGB1在I-LSCC中的表达(4.35±1.33)高于在LPLs(3.12±0.95)及VP(2.11±0.71)中(均P<0.001).HMGB1表达在喉黏膜低级别异型增生、高级别异型增生及原位癌之间无明显差异(P>0.05).36.59%的I-LSCC同时具有HMGB1高表达及Ki-67高表达,且HMGB1高表达组和低表达组的Ki-67阳性率差异有统计学意义(P=0.01);33.33%的I-LSCC同时具有HMGB1高表达及淋巴结转移,且HMGB1高表达组和低表达组的淋巴结转移率差异有统计学意义(P<0.001);47.15%的I-LSCC同时具有HMGB1高表达及高临床分期(Ⅲ期及Ⅳ期),且HMGB1高表达组和低表达组的临床分期差异有统计学意义(P<0.001).HMGB1表达与年龄、性别、吸烟指数、饮酒情况及癌细胞分化程度无明显差异(均P>0.05).HMGB1高表达的I-LSCC患者预后较HMGB1低表达的患者更差(P<0.05).结论:HMGB1在I-LSCC中高表达,可能在I-LSCC的发生和发展中起重要作用.

Objective:Early diagnosis and intervention of invasive laryngeal squamous cell carcinoma(I-LSCC)are the key to reducing its incidence and mortality rates.This study aims to explore the role and clinical significance of high mobility group box-1(HMGB1)protein in the occurrence and development of I-LSCC. Methods:A total of 281 paraffin-embedded specimens collected from Department of Pathology,Beijing Tongren Hospital,Capital Medical University from November 2009 to June 2011 were included,comprising 123 cases of I-LSCC,103 cases of laryngeal precursor lesions(LPLs)(31 cases of low-grade dysplasia,49 cases of high-grade dysplasia,and 23 cases of carcinoma in situ),and 55 cases of vocal polyps(VP).Immunohistochemical staining was used to detect the expression of HMGB1 and Ki-67 in the specimens.The combined score of HMGB1 positivity intensity and positivity rate ranged from 0 to 7,with scores of 0 to 4 indicating low expression and 5 to 7 indicating high expression.Ki-67 positivity rate≥50%was considered high expression,while<50%was considered low expression. Results:The expression of HMGB1 in I-LSCC(4.35±1.33)was higher than that in LPLs(3.12±0.95)and VP(2.11±0.71)(both P<0.001).There was no significant difference in HMGB1 expression among low-grade dysplasia,high-grade dysplasia,and carcinoma in site of the laryngeal mucosa(P>0.05).High expressions of HMGB1 and Ki-67 were observed in 36.59%of I-LSCC cases(P=0.01),and there was a statistically significant difference in Ki-67 positivity rate between the high and low expression groups of HMGB1(P=0.01).High expression of HMGB1 and lymph node metastasis were also observed in 33.33%of I-LSCC cases,and there was a statistically significant difference in lymph node metastasis rate between the high and low expression groups of HMGB1(P<0.001).High expressions of HMGB1 and advanced clinical stage were found in 47.15%of I-LSCC cases(stage Ⅲ and Ⅳ),and there was a statistically significant difference in clinical stage between the high and low expression groups of HMGB1(P<0.001).There were no significant differences in HMGB1 expression with respect to age,gender,smoking index,alcohol consumption,or cancer cell differentiation degree(all P>0.05).Patients with high HMGB1 expression in I-LSCC had a worse prognosis than those with low HMGB1 expression(P<0.05). Conclusion:HMGB1 is highly expressed in I-LSCC,suggesting its significant role in the occurrence and development of I-LSCC.

苏才丽;滕孝静;王苗;岳冰;陈光勇;刘红刚

首都医科大学附属北京友谊医院病理科,北京 100050首都医科大学附属北京同仁医院病理科/头颈部分子病理诊断北京市重点实验室,北京 100730

喉黏膜异型增生浸润性喉鳞状细胞癌高迁移率族蛋白B1

laryngeal mucosa dysplasiainvasive laryngeal squamous cell carcinomahigh mobility group box-1

《临床与病理杂志》 2024 (001)

38-44 / 7

北京市教育委员会科技计划项目(KZ201910025033).This work was supported by the Beijing Municipal Education Commission,China(KZ201910025033).

10.11817/j.issn.2095-6959.2024.230224

评论